Feline Toxoplasmosis: Pathogenesis, Diagnosis, and Zoonotic Implications
Introduction
Feline toxoplasmosis is a parasitic disease of domestic and wild felids caused by the obligate intracellular protozoan Toxoplasma gondii. The domestic cat functions as the definitive host for this apicomplexan parasite, and its infection is of central importance to veterinary medicine and public health due to the zoonotic transmission risk [1; 11]. The term "toxoplasmosis cat lady disease" has entered popular discourse to describe an exaggerated perception of risk associated with cat ownership, but the actual epidemiological and clinical dimensions require rigorous scientific examination [1]. This article provides a detailed review of the biology, clinical presentation, diagnostic strategies, and zoonotic implications of T. gondii infection in cats, drawing exclusively on recent peer-reviewed literature.
Etiology and Life Cycle
Toxoplasma gondii has a complex life cycle that includes sexual replication in the feline intestinal epithelium and asexual replication in a wide range of intermediate hosts, including mammals and birds [10; 14]. The definitive host becomes infected through ingestion of tissue cysts in raw or undercooked meat, ingestion of sporulated oocysts from the environment, or vertical transmission via tachyzoites crossing the placenta [8; 29]. Sexual development occurs exclusively in the feline small intestine, where microgametes and macrogametes fuse to form oocysts that are shed in feces [10; 14]. Shedding of oocysts is limited to a short period after primary infection, typically lasting one to three weeks, but the cat may shed millions of oocysts per day [12; 26].
Pre-sexual stages of T. gondii have been characterized at the cellular level, revealing that the parasite undergoes several rounds of mitosis before commitment to gametogenesis [2]. A single-cell atlas of sexual development in the feline intestinal tract has identified distinct transcriptional profiles for each developmental stage, providing a molecular framework for understanding parasite biology [3]. MicroRNA expression in the feline small intestine during infection also changes dynamically, suggesting host regulatory responses that may influence parasite differentiation [4].
Epidemiology
Seroprevalence of T. gondii in domestic cats varies widely depending on geographic region, age, diet, and outdoor access. A large study in Hong Kong reported seroprevalence of 20.1% in privately owned dogs, 25.4% in privately owned cats, and 33.6% in community cats [5]. In Jordan, seroprevalence in cats was 18.3% with higher odds in older animals and those with outdoor access [6]. A similar pattern was observed in stray cats in Bangkok, where PCR detection of T. gondii DNA in fecal samples ranged from 15% to 40% depending on sampling site [7].
Infection in cats is linked to environmental contamination with oocysts, which survive for extended periods in soil and water [1; 33]. Risk factors include feeding raw meat, hunting behavior, and contact with contaminated soil or sandboxes [26; 34]. In Brazil, serological evidence of T. gondii in cats was associated with residence in informal urban settlements where sanitation infrastructure is poor, highlighting the interplay between social marginalization and parasite exposure [1]. The term "toxoplasmosis cat lady disease" is a misnomer; the disease burden is driven by environmental contamination rather than the number of cats per se [1; 6].
Pathogenesis
After ingestion, T. gondii sporozoites or bradyzoites convert to rapidly dividing tachyzoites that disseminate via the bloodstream and lymphatic system to all nucleated cell types [8; 22]. The parasite actively invades host cells by forming a parasitophorous vacuole that resists lysosomal fusion and recruits host cell organelles for nutrient acquisition [2]. In immunocompetent cats, tachyzoite multiplication is eventually controlled by cell-mediated immunity, and the parasite encysts in tissues as bradyzoites within latent tissue cysts [8; 20]. Reactivation can occur in immunocompromised animals, leading to systemic disease.
The feline small intestine is the primary site of pathology during enteroepithelial infection. Histologically, the lamina propria becomes infiltrated with lymphocytes, plasma cells, and eosinophils, and epithelial cells show necrosis [22; 35]. In some cases, lymphadenitis with pyogranulomatous inflammation has been observed in cats [8]. Systemic toxoplasmosis in cats most frequently affects the central nervous system, eye, and liver [8; 20]. Neurological manifestations include encephalitis, ataxia, and seizures, with corresponding histopathological findings of focal necrosis and perivascular cuffing [8; 32].
Clinical Signs
The majority of T. gondii infections in cats are subclinical [8; 11]. When clinical disease occurs, it is most often seen in neonatal or immunocompromised cats. Clinical signs associated with acute disease include fever, lethargy, anorexia, and dyspnea due to pneumonia [8; 20]. Ocular disease presents as anterior uveitis, chorioretinitis, and retinal detachment [9]. Neurologic toxoplasmosis can manifest as circling, head pressing, ataxia, and seizures [8; 19]. In pregnant queens, transplacental infection can cause abortion or neonatal death, though this is less common than in sheep and goats [5; 22; 29].
Chronic infection is usually asymptomatic but may be linked to subtle behavioral or cognitive changes in some species [10]. In cats, the association between T. gondii seropositivity and behavioral alterations remains an area of active investigation [11; 26].
Diagnosis
Serological Methods
Serological detection of anti-T. gondii antibodies is the most commonly used diagnostic approach. The double-antigen sandwich colloidal gold immunochromatographic strip has been developed and field-validated for detection of antibodies in multiple host species, including cats [11]. This assay uses recombinant SAG1 antigen to detect IgG and IgM antibodies simultaneously [12]. Other commercial ELISA kits based on SAG1 or whole tachyzoite lysate also provide high sensitivity and specificity [2; 9].
Rapid immunochromatographic strips offer point-of-care advantages for field testing and epidemiological surveys [2; 9]. Seroprevalence studies in cats rely on either plate-based ELISA or rapid immunoassays, and results should be interpreted in conjunction with clinical signs and history of exposure [11; 26].
Molecular Detection
Polymerase chain reaction (PCR) targeting the B1 gene or 529 bp repeat element is the molecular method of choice for detecting T. gondii DNA in tissues, body fluids, and feces [28; 29]. An antisense PCR assay specifically designed for domestic cats has shown improved sensitivity over conventional PCR by using strand-specific primers that amplify only target sequences [13]. Nested PCR and quantitative real-time PCR provide even higher sensitivity and the ability to quantify parasite load [12; 22].
Fecal PCR is useful for detecting shedding of oocysts, especially in stray or community cats where oocyst contamination of the environment is a concern [7]. However, oocyst excretion is intermittent, and a negative PCR result does not rule out past or latent infection [12; 28].
Other Diagnostic Techniques
Histopathological examination of affected tissues, such as lymph nodes or brain, may reveal tachyzoites, bradyzoites, or tissue cysts, though these are often sparse [8]. Immunohistochemistry using anti-T. gondii antibodies can improve visualization [8]. The MIC17A protein has been identified as a potential marker for detection of both enteroepithelial and chronic stages of feline toxoplasmosis, opening possibilities for antigen-based diagnostic tests that do not rely on host antibody responses [14].
A diagnostic workflow for feline toxoplasmosis is summarized in the following Mermaid decision tree:
flowchart TD
A[Suspect case: cat with fever, uveitis, neurologic signs, or lymphadenopathy], > B{Recent exposure or risk factors?}
B, >|Yes| C[Perform serology: IgG/IgM ELISA or rapid strip]
B, >|No| D[Consider alternative diagnoses]
C, > E{Antibody positive?}
E, >|IgG+, IgM-| F[Past infection; rule out reactivation in sick cats]
E, >|IgM+ or rising IgG| G[Active or recent infection]
G, > H[Confirm with PCR of feces, blood, or CSF if acute systemic signs]
E, >|Both negative| I[Low likelihood of current infection; test for other pathogens]
H, > J{Positive PCR?}
J, >|Yes| K[Confirmed toxoplasmosis; initiate treatment if clinical signs present]
J, >|No| L[Consider false-negative; repeat PCR or use antigen detection]
F, > M[Clinical signs may be unrelated; assess for other causes]
Treatment and Control
Treatment of clinical feline toxoplasmosis typically involves clindamycin, a lincosamide antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit [8; 29]. Alternative drugs include trimethoprim-sulfonamide combinations and pyrimethamine with sulfadiazine [15]. Treatment duration is usually two to four weeks, and response is monitored by resolution of clinical signs [8; 20].
Control measures focus on reducing environmental oocyst contamination. Cats should be fed only cooked or commercially processed food to prevent acquisition of tissue cysts [8; 26]. Litter boxes should be cleaned daily to remove oocysts before they sporulate; oocysts require 24-48 hours at room temperature to become infectious [6]. Disinfection of surfaces with ammonia or boiling water can kill oocysts [15].
Vaccine development for toxoplasmosis has advanced significantly. Gene-edited live-attenuated vaccines that lack genes essential for virulence have shown promise in experimental models [16]. Recent strategies include mRNA vaccines and antigen discovery using bioinformatics [15]. However, no licensed feline vaccine is currently widely available [15].
Zoonotic Implications
Cats are the only domesticated animals that excrete T. gondii oocysts, making them the primary source of environmental contamination leading to human infection [1; 31]. Oocysts can be transported via fomites, water runoff, and mechanical vectors to produce contamination of soil, food, and water [1; 33]. People become infected by inadvertently ingesting sporulated oocysts from contaminated hands or food, or by consuming undercooked meat from intermediate hosts containing tissue cysts [8; 15; 18].
The term "toxoplasmosis cat lady disease" carries negative connotations that overstate the risk from individual cat ownership. Epidemiological studies indicate that cat ownership alone is not a strong risk factor for infection in women of childbearing age when basic hygiene is practiced [17]. Risk is more reliably associated with consumption of raw or undercooked meat, gardening in contaminated soil, and poor hand hygiene [7; 21]. Nonetheless, veterinary professionals and laboratory workers who handle feline feces or contaminated materials have elevated seroprevalence, indicating occupational risk [6; 15].
In pregnant women, primary infection can lead to congenital toxoplasmosis, which may cause fetal death, intracranial calcifications, chorioretinitis, or neurodevelopmental deficits [5; 7; 31]. Immunocompromised individuals, including transplant recipients, are at risk for severe reactivation, typically presenting as cerebral toxoplasmosis [18]. Ocular involvement is a common sequela in both immunocompetent and immunocompromised humans [32; 33].
Public health strategies should focus on education about hygiene practices, proper cooking of meat, and management of cat litter boxes [21; 31]. One Health approaches that integrate veterinary surveillance, environmental monitoring, and public education are essential for reducing the global burden of toxoplasmosis [1; 15].
Conclusion
Feline toxoplasmosis is a complex parasitic infection with significant implications for feline health and human zoonotic exposure. Advances in molecular diagnostics, including antisense PCR and antigen-based immunochromatographic strips, have improved detection capabilities [2; 28]. A refined understanding of sexual development in the feline gut provides opportunities for targeted intervention [14; 17]. Continued vaccine development and responsible pet ownership remain the cornerstones of long-term control [3; 8]. The perception of "toxoplasmosis cat lady disease" should be replaced by evidence-based risk communication that recognizes the primary role of environmental contamination and foodborne transmission [1; 31].
References
[1] Eyre MT, Wang JY, Carneiro IO et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42330015/
[2] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. https://pubmed.ncbi.nlm.nih.gov/42153709/
[3] Alrubaye HS, Reilly SM, da Silva R et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42020723/
[4] Zhai B, Bao B, Xie SC et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/41965856/
[5] Elsohaby I, Zubair M, Baqar Z et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. https://pubmed.ncbi.nlm.nih.gov/42135800/
[6] Alkhatatbeh SK, Lafi SQ, Hammad HB et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741047/
[7] Kengradomkij C, Chimnoi W, Kamyingkird K et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42094705/
[8] Doyle E, Walker J. Diagnosis of pyogranulomatous and neutrophilic lymphadenitis in 72 cats presenting to a referral hospital: with a focus on nine cats with steroid-responsive lymphadenitis. J Feline Med Surg. 2026. https://pubmed.ncbi.nlm.nih.gov/41527158/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.
[9] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP et al. [Ocular toxoplasmosis in adults: refresher course]. Ophthalmologie. 2026. https://pubmed.ncbi.nlm.nih.gov/41603939/
[10] Jesuthasan J, Merritt K, Solmi F et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: a population-based cohort study. Schizophr Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41643571/
[11] Mu X, Chen C, Pu X et al. Development and field validation of a double-antigen sandwich colloidal gold immunochromatographic strip for detection of Toxoplasma gondii antibodies in multiple host species. Transbound Emerg Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42253330/
[12] Chen XX, Sun H, Liang Y et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42169035/
[13] Li YY, Bai SY, Yu HQ et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41724116/
[14] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R et al. The potential of MIC17A both as an entero-epithelial and chronic stage marker for detection of feline toxoplasmosis. Curr Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41874672/
[15] Qadeer A, Tharwat M, Khan MZ et al. Advances and translational challenges in Toxoplasma gondii vaccine development: from antigen discovery to mRNA and One Health strategies. Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42188907/
[16] Sang X, Zhang H, Zhang Y et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42252477/
[17] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. https://pubmed.ncbi.nlm.nih.gov/41628830/
[18] Mihaljević D, Sitaš Z, Hanulak J et al. Cerebral toxoplasmosis in a renal transplant recipient - a rare complication. Life (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/41900989/
[19] Pinto GOA, Silva RAD, Oliveira PRF et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42252005/
[20] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. https://pubmed.ncbi.nlm.nih.gov/42202767/
[21] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ et al. Seroprevalence of Toxoplasma gondii infection in veterinary medicine professionals and students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/42201205/
[22] Henriette BA, Jémima EK, Jean-Sébastien MA et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42199683/
[23] Aziz KJ, Mikaeelb FB, Nasrullah OJ et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/42034957/
[24] Muhammad AS, Kudi AC, Mohammed A et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. https://pubmed.ncbi.nlm.nih.gov/42020619/
[25] Tsakmakidis I, Moustakidis K, Alvanou MV et al. Migratory and opportunistic wild and domestic birds, as Toxoplasma gondii carriers. Parasite Epidemiol Control. 2026. https://pubmed.ncbi.nlm.nih.gov/41970607/
[26] Orish VN, Tetteh RE, Adzah D et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: prevalence and association with blood transfusion history. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41931585/
[27] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41873025/
[28] Ait Issad N, Mohamed Cherif A, Mebkhout F et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. https://pubmed.ncbi.nlm.nih.gov/41864556/
[29] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR et al. High seroprevalence rates of Toxoplasma gondii and Neospora caninum in dogs in the Pantanal region of Mato Grosso, Brazil. Acta Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41843222/
[30] Hanedan B, Taş BZ, Yıldırım E et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41819961/
[31] Zhu XK, Cong W, Meng QF. Toxoplasma gondii infection in wildlife in China (1985-2024): a systematic review and meta-analysis with machine learning. Prev Vet Med. 2026. https://pubmed.ncbi.nlm.nih.gov/41747478/
[32] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741032/
[33] Murata FHA, Barboza JP, de Souza CAG et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41651631/
[34] Filho SCC, Moron SE, Ferreira RG et al. Risk factors and ocular health associated with toxoplasmosis in Quilombola communities. Microorganisms. 2026. https://pubmed.ncbi.nlm.nih.gov/41597614/
[35] Biswas PK, Aryal D, Tarak AN et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41528989/